Extracellular vesicles (EVs) secreted by cancer cells provide an important insight into cancer
biology and could be leveraged to enhance diagnostics and disease monitoring. This paper …

Circulating cancer-derived small extracellular vesicles (EVs) are nanoscale membranous
vesicles shed from cancer cells that are released into surrounding body fluids. Small EVs …

Mammalian cells release extracellular vesicles (EVs) into their microenvironment that travel
the entire body along the stream of bodily fluids. EVs contain a wide range of biomolecules …

Extracellular vesicles (EVs) are continually released from cancer cells into biofluids, carrying
actionable molecular fingerprints of the underlying disease with considerable diagnostic and …

Exosomes, nano‐sized extracellular vesicles (EVs) secreted from cells, carry various cargo
molecules reflecting their cells of origin. As EV content, structure, and size are highly …

Given the emerging diagnostic utility of extracellular vesicles (EVs), it is important to account
for non-EV contaminants. Lipoprotein present in EV-enriched isolates may inflate particle …

Cancer-derived small extracellular vesicles (sEVs) are specific subgroups of lipid bilayer
vesicles secreted from cancer cells to the extracellular environment. They carry distinct …

In cancer, extracellular vesicles (EV) contribute to tumor progression by regulating local and
systemic effects. Being released into body fluids, EV may be used in nanomedicine as a …

Breast cancer subtypes have important implications of treatment responses and clinical
outcomes. Exosomes have been considered as promising biomarkers for liquid biopsies, but …

Extracellular vesicles (EVs), including exosomes, are promising circulating biomarkers for
disease diagnosis. Conventional EVs analysis requires multiple instrumentations to obtain …